English Abstract Journal Article Ahead of print
PubMed: 40628553 DOI: 10.1016/j.bulcan.2025.04.011
[Neoadjuvant imatinib treatment of locally advanced gastrointestinal stromal tumours: Theory and practice].
Bull Cancer
Authors: Nicolas Penel, Antoine Cayeux, Gauthier Decanter, Loïc Lebellec
Affiliations
- Département d'oncologie médicale, centre Oscar-Lambret, 3, rue Combemale, 59020 Lille cedex, France; ULR 2694 - Metrics : évaluation des technologies de santé et des pratiques médicales, CHU de Lille, université de Lille, Lille, France.
- Département de chirurgie, centre Oscar-Lambret, 3, rue Combemale, 59020 Lille cedex, France.
- Département d'oncologie médicale, centre Oscar-Lambret, 3, rue Combemale, 59020 Lille cedex, France.
Abstract
In this review we summarised published clinical trials evaluating neoadjuvant treatment with imatinib for locally advanced gastro-intestinal stromal tumours. We illustrate the practice through a clinical vignette, allowing us to highlight practical suggestions.
MeSH
Neoplasms, Therapeutics